XML 44 R30.htm IDEA: XBRL DOCUMENT v3.24.0.1
Note 22 - Equity-based Compensation
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

22. EQUITY-BASED COMPENSATION

 

The following table summarizes the amounts the Company recognized as equity-based compensation expense including restricted stock, restricted units, membership units of consolidated sponsor entities and stock options. These amounts are included as a component of compensation and benefits in the consolidated statements of operations. The remaining unrecognized compensation expense related to unvested awards at December 31, 2023 was $10,719 and the weighted average period of time over which this expense will be recognized is approximately 1.8 years. 

 

 

 

 

EQUITY-BASED COMPENSATION INCLUDED IN COMPENSATION AND BENEFITS

(Dollars in Thousands)

 

  

For the Year Ended December 31,

 
  

2023

  

2022

  

2021

 

Equity based compensation expense

 $4,391  $4,390  $15,718 

Non equity-based compensation expense

  47,701   45,900   69,330 

Total compensation and benefits

 $52,092  $50,290  $85,048 

 

The following table summarizes the equity-based compensation by plan.  Each plan is discussed in detail below.

 

DETAIL OF EQUITY-BASED COMPENSATION BY PLAN

(Dollars in Thousands)

 

  

For the Year Ended December 31,

 
  

2023

  

2022

  

2021

 

Restricted Stock or Units - 2006/2010 Plans

 $-  $21  $291 

Restricted Stock or Units - 2020 Plan

  4,391   4,369   2,359 

Membership interests in consolidated sponsor entities

  -   -   13,068 

Total equity-based compensation expense

 $4,391  $4,390  $15,718 

 

The Company’s 2020 Long-Term Incentive Plan – Restricted Common Stock, Restricted Units and Stock Options

 

On April 7, 2020, the board of directors of the Company adopted a long-term incentive plan (the “2020 Long Term Incentive Plan”), which was approved by the Company’s stockholders at the Company’s annual meeting on June 18, 2020. On April 1, 2021 and June 9, 2021, the board of directors and the Company stockholders, respectively, approved Amendment No. 1 to the 2020 Long-Term Incentive Plan, which increased the maximum number of shares of common stock available for issuance under the 2020 Long-Term Incentive Plan from 600,000 shares of common stock to 1,200,000 shares of common stock. On March 28, 2022 and June 2, 2022, the board of directors and the Company stockholders, respectively, approved Amendment No. 2, which increased, the maximum number of shares of common stock available for issuance under the 2020 Long-Term Incentive Plan, as amended, from 1,200,000 shares of common stock to 1,900,000 shares of common stock.  As of  December 31, 2023,579,391 shares remain available to be issued under the Company's 2020 Long-term Incentive Plan. No award may be granted under the 2020 Long Term Incentive Plan after April 7, 2030.

 

The Company's 2010 Long- Term-Incentive Plan and the AFN 2006 Equity Plan expired in 2020 and there are no shares available to be issued under these plans.

 

Membership Interests of Consolidated Sponsor Entities

 

Employees sometimes invest in the membership interests of consolidated SPAC sponsor entities.  Because these entities are consolidated and the employees are investing in the consolidated company's non-controlling interest, these equity interests fall under FASB ASC 718.  Generally, the employee invests a de minimis amount and receives an allocation of the founder shares held by the sponsor entity.  The investment generally does not have any explicit vesting criteria associated with it.  Generally, the employee's investment will be worthless if the SPAC in which the sponsor entity has invested is liquidated and it will become worth something if the SPAC completes its business combination.  Therefore, the Company treats these grants as having a performance condition (i.e. the completion of the SPAC business combination).  Further, at the time of the investments, the Company treats this performance condition as being non-probable.  The effect of this is that the Company records no expense related to these investments until (and only if) the business combination is completed.  Upon completion of the business combination, the Company records compensation expense in an amount equal to the fair value of the grant.  The fair value of the grant is equal to the public trading price of the SPAC on the grant date adjusted for certain sale restrictions imposed on the shares the employee receives (generally, the shares are restricted for sale for some time period and subject to certain hurdle prices before they become freely tradeable).  

 

RESTRICTED STOCK - SERVICE BASED VESTING

 

  

Number of Shares of Restricted Stock

  

Weighted Average Grant Date Fair Value

 

Unvested at January 1, 2021

  286,566  $14.23 

Granted

  142,376   17.94 

Vested

  (62,649)  7.59 

Unvested at December 31, 2021

  366,293   16.80 

Granted

  92,400   11.13 

Vested

  (117,634)  14.08 

Unvested at December 31, 2022

  341,059   16.17 

Granted

  143,900   7.57 

Vested

  (113,301)  17.18 

Forfeiture

  (4,167)  (11.65)

Unvested at December 31, 2023

  367,491   12.54 

 

 

 

  

 

OPERATING LLC RESTRICTED UNITS - SERVICE BASED VESTING

 

  

Number of Restricted Units

  

Weighted Average Grant Date Fair Value

 

Unvested at January 1, 2021

  2,783,080  $1.46 

Granted

  4,617,000   2.07 

Vested

  (529,050)  0.62 

December 31, 2021

  6,871,030   1.46 

Granted

  422,000   1.93 

Vested

  (751,540)  0.85 

Unvested at December 31, 2022

  6,541,490   1.35 

Granted

  422,000   0.68 

Vested

  (1,438,160)  1.97 

Unvested at December 31, 2023

  5,525,330  $1.82 

 

During the years ended December 31, 2023, 2022, and 2021, the total fair value of all equity awards vested in each year based on the fair market value of the Common Stock on the vesting date was $2,249, $2,899, and $1,999, respectively.

 

The restricted shares and restricted units of Common Stock typically may vest either quarterly, annually, or at the end of a specified term on a straight-line basis over the remaining term of the awards, assuming the recipient is continuing in service to the Company at such date, and, in the case of performance-based equity awards, the performance thresholds have been attained. In the case of director grants, the equity awards have no performance or service conditions.  In the cases of graded vesting, the Company typically expenses the grant on a straight-line basis if only service conditions are present but expenses on a graded basis if performance-based conditions are present.

 

 

SPONSOR ENTITY MEMBERSHIP UNITS - PERFORMANCE BASED VESTING

 

  

Membership Units

  

Weighted Average Grant Date Fair Value

 

Unvested at January 1, 2021

  3,272,500  $9.98 

Granted

  -   - 

Vested

  (1,309,000)  9.99 

Forfeited

  (231,000)  9.99 

December 31, 2021

  1,732,500   9.97 

Granted

  -   - 

Vested

  -   - 

Forfeited

  (1,732,500)  9.97 

Unvested at December 31, 2022

  -   - 

Granted

  -   - 

Vested

  -   - 

Forfeited

  -   - 

Unvested at December 31, 2023

  -  $- 
         

   

During the years ended December 31, 2023, 2022, and 2021, the total fair value of all equity awards vested in each year based on the fair market value of the membership units on the vesting date was $0, $0, and $13,361, respectively.